Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

[25 hydroxyvitamin D levels and cardiovascular risk in a cohort of patients with advanced chronic kidney disease].

García-Cantón C, Bosch E, Auyanet I, Ramírez A, Rossique P, Culebras C, Sánchez A, Toledo A, Lago M, Esparza N, Checa MD.

Nefrologia. 2010;30(4):435-42. doi: 10.3265/Nefrologia.pre2010.Mar.10288. Spanish.

2.

Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5.

García-Canton C, Bosch E, Ramírez A, Gonzalez Y, Auyanet I, Guerra R, Perez MA, Fernández E, Toledo A, Lago M, Checa MD.

Nephrol Dial Transplant. 2011 Jul;26(7):2250-6. doi: 10.1093/ndt/gfq650. Epub 2010 Oct 18.

PMID:
20956810
3.

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.

Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W.

Arch Intern Med. 2008 Jun 23;168(12):1340-9. doi: 10.1001/archinte.168.12.1340.

PMID:
18574092
4.

Vitamin D status and mortality risk in patients with chronic kidney disease.

Santoro D, Gitto L, Ferraro A, Satta E, Savica V, Bellinghieri G.

Ren Fail. 2011;33(2):184-91. doi: 10.3109/0886022X.2011.553303.

PMID:
21332341
5.

Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.

Chitalia N, Raja RB, Bhandara T, Agrawal P, Kaski JC, Jha V, Banerjee D.

J Nephrol. 2010 Jan-Feb;23(1):77-84.

PMID:
20091490
6.

Vitamin D and cardiovascular disease risk.

Michos ED, Melamed ML.

Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):7-12. Review.

PMID:
18090651
7.

Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up.

Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njølstad I, Schirmer H, Jorde R.

Diabet Med. 2010 Oct;27(10):1107-15. doi: 10.1111/j.1464-5491.2010.03092.x.

PMID:
20854377
8.

Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease.

Inaguma D, Nagaya H, Hara K, Tatematsu M, Shinjo H, Suzuki S, Mishima T, Kurata K.

Clin Exp Nephrol. 2008 Apr;12(2):126-31. doi: 10.1007/s10157-007-0023-4. Epub 2008 Jan 9.

PMID:
18180871
9.

Cardiorespiratory fitness is independently associated with 25-hydroxyvitamin D in chronic kidney disease.

Petchey WG, Howden EJ, Johnson DW, Hawley CM, Marwick T, Isbel NM.

Clin J Am Soc Nephrol. 2011 Mar;6(3):512-8. doi: 10.2215/CJN.06880810. Epub 2010 Dec 16.

10.

Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease.

Rucker D, Tonelli M, Coles MG, Yoo S, Young K, McMahon AW.

J Nephrol. 2009 Jan-Feb;22(1):75-82.

PMID:
19229821
11.

Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.

Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr.

J Am Geriatr Soc. 2009 Sep;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x. Epub 2009 Jun 22.

PMID:
19549021
12.

Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD).

Goicoechea M, de Vinuesa SG, Gómez-Campderá F, Luño J.

Kidney Int Suppl. 2005 Jan;(93):S35-8.

PMID:
15613066
13.

Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease.

Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina SM, Levey AS, Sarnak MJ.

Am J Kidney Dis. 2003 Jul;42(1):44-52.

PMID:
12830455
14.

Serum 25-hydroxyvitamin D concentrations are associated with erythrocyte levels of n-3 PUFA but not risk of CVD.

Park Y, Kim M.

Br J Nutr. 2011 Nov;106(10):1529-34. doi: 10.1017/S0007114511001930. Epub 2011 Jun 1.

PMID:
21736802
15.

A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population.

Bang UC, Semb S, Nordgaard-Lassen I, Jensen JE.

Nutr Res. 2009 Sep;29(9):671-5. doi: 10.1016/j.nutres.2009.09.010.

PMID:
19854383
16.

25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III).

de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS.

Am J Kidney Dis. 2007 Jul;50(1):69-77.

PMID:
17591526
17.

Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk.

Goicoechea M, Garca de Vinuesa S, Gómez-Campderá F, Gutierrez MJ, Blanco P, Amann R, Luño J.

Am J Kidney Dis. 2004 May;43(5):846-53.

PMID:
15112175
18.

Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients.

Fourtounas C, Vlachojannis JG.

Am J Clin Nutr. 2009 Jan;89(1):436; author reply 436-8. doi: 10.3945/ajcn.2008.26770. Epub 2008 Dec 3. No abstract available.

19.

[Cardioprotective effect of vitamin D in nondialyzed patients with stage 3-5 CKD].

Cozzolino M, Mehmeti F, Bonelli F, Ronga C, Musetti C, Missaglia E, Stucchi A, Colombo F, Tavecchia M, Cuoccio P, Brenna I, Volpi E, Ciceri P, Cusi D.

G Ital Nefrol. 2010 Nov-Dec;27 Suppl 52:S27-31. Italian.

PMID:
21132659
20.

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.

Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K.

Arch Intern Med. 2007 Jun 11;167(11):1159-65.

PMID:
17563024

Supplemental Content

Support Center